Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05759143 · ClinicalTrials.gov registry record · NA
Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing
A NA study of Genetic Predisposition and Genetic Predisposition to Disease, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05759143: Recruiting NA study of Genetic Predisposition and Genetic Predisposition to Disease, sponsored by Dana-Farber Cancer Institute.
NCT05759143 is a NA study of Genetic Predisposition and Genetic Predisposition to Disease that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 40 participants, below the 3,517-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05759143, a NA study of Genetic Predisposition and Genetic Predisposition to Disease, is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain significance (VUS). The name of the intervention used in this research study is: Nest portal (electronic platform for patients and clinicians)
Primary Outcome
Defined as \> 70% of consenting participants who use the intervention.
Conditions Studied
Interventions
- BEHAVIORAL Nest Platform
Study Locations (1)
Massachusetts
- Dana Farber Cancer Institute - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-05-01 |
| Est. Completion | 2026-07-30 |
| Phase | NA |
What NCT05759143 shows while recruiting
NCT05759143 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 3,517-participant average among 14 other Genetic Predisposition trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Genetic Predisposition appearing as the primary indexed condition, and to 1 intervention - of which Nest Platform is the first listed.
NCT05759143 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05759143 about?
NCT05759143 is a clinical study titled "Enhancing Information Management for Young Adults After Genetic Cancer Risk Testing". This research is being done to develop the electronic platform Nest for young adults (ages 18-39) who have had prior cancer genetic testing. The platform will give patients and their clinicians access to continuously updated information about both pathogenic variants and variants of uncertain signif...
What is the current status of trial NCT05759143?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-05-01. Estimated completion is 2026-07-30.
What conditions does trial NCT05759143 study?
This clinical trial studies the following conditions: Genetic Predisposition, Genetic Predisposition to Disease.
What interventions are being tested in trial NCT05759143?
The interventions under investigation include: Nest Platform (BEHAVIORAL).
Who is sponsoring clinical trial NCT05759143?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05759143 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Predisposition
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05759143's enrollment target sits among peer trials
40 14th of 14 the lowest of 14 other Genetic Predisposition trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Genetic Predisposition trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Using the EHR to Advance Genomic Medicine Across a Diverse Health System
RECRUITING · NA
-
Genetic Information Assistant in Telegenetics
RECRUITING · NA
-
Effectiveness of MyCancerGene to Optimize Genetic Testing Outcomes
ACTIVE NOT RECRUITING · NA
-
Overcoming Barriers to Accessing Genetic Medicine
ACTIVE NOT RECRUITING · NA
-
Early Detection of GEnetic Risk (EDGE)
COMPLETED · NA
-
InterNatIonal CHildhood Leukemia Microbiome/MEtabolome Cohort
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI